THE ANTIMICROBIAL PEPTIDE LL-37 AND TYPE I INTERFERON IN IDIOPATHIC INFLAMMATORY MYOPATHIES

被引：0
|
作者：
Lu, X. [1 ]
Tang, Q. [2 ]
Lindroos, E. [2 ]
Lindh, M. [3 ]
Agerberth, B. [3 ]
Lundberg, I. [2 ]
Wick, C. [2 ]
机构：
[1] China Japan Friendship Hosp, Dept Rheumatol, Beijing, Peoples R China
[2] Karolinska Inst, Karolinska Univ Hosp, Rheumatol Unit, Dept Med, Stockholm, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Clin Microbiol, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5559
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0187
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [1] Expression of Anti-Microbial Peptide LL-37 Correlates to the Activation of Type I Interferon Pathway in Patients with Idiopathic Inflammatory Myopathies
    Lu, Xin
    Tang, Quan
    Lindh, Monica
    Agerberth, Birgitta
    Dastmalchi, Maryam
    Lundberg, Ingrid E.
    Wick, Cecilia
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Human antimicrobial peptide LL-37
    Yang, YH
    Ma, WR
    Zheng, GG
    Wu, KF
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2003, 30 (06) : 847 - 851
  • [3] Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease
    Kim, ST
    Cha, HE
    Kim, DY
    Han, GC
    Chung, YS
    Lee, YJ
    Hwang, YJ
    Lee, HM
    ACTA OTO-LARYNGOLOGICA, 2003, 123 (01) : 81 - 85
  • [4] Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
    Reinholz, Markus
    Ruzicka, Thomas
    Schauber, Juergen
    ANNALS OF DERMATOLOGY, 2012, 24 (02) : 126 - 135
  • [5] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [6] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Robert Bucki
    Katarzyna Leszczyńska
    Andrzej Namiot
    Wojciech Sokołowski
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 15 - 25
  • [7] Antimicrobial peptide LL-37 in human atherosclerosis
    Edfeldt, K.
    Agerberth, B.
    Rottenberg, M. E.
    Gudmundsson, G. H.
    Mandal, K.
    Xu, Q. B.
    Hansson, G. K.
    Yan, Z. Q.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 407 - 407
  • [8] Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides
    Martynowycz, Michael
    Rice, Amy
    Andreev, Konstantin
    Pavinatto, Thatyane M. Nobre
    Wereszczynski, Jeff
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 45A - 45A
  • [9] Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages
    Ruan, Yang
    Shen, Tao
    Wang, Yan
    Hou, Man
    Li, Jian
    Sun, Tieying
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 15 (03) : 575 - 580
  • [10] The type I interferon system in idiopathic inflammatory myopathies
    Lundberg, Ingrid E.
    Helmers, Sevim Barbasso
    AUTOIMMUNITY, 2010, 43 (03) : 239 - 243
12345